Icosavax, Inc. (ICVX)
Feb 20, 2024 - ICVX was delisted (reason: acquired by AstraZeneca)
15.31
0.00 (0.00%)
Inactive · Last trade price
on Feb 16, 2024
Icosavax Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$25.00
Upside
+63.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 2, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +82.89% | Nov 17, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $25 | Buy | Reiterates | $25 | +63.29% | Oct 2, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $27 | Buy | Reiterates | $27 | +76.36% | Apr 25, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $27 | Buy | Initiates | $27 | +76.36% | Jan 4, 2023 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 23, 2021 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 23, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Aug 23, 2021 |